Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Conjugated estrogens oral - Teva Pharmaceutical Industries

Drug Profile

Conjugated estrogens oral - Teva Pharmaceutical Industries

Alternative Names: Cenestin; Synthetic conjugated estrogens, A

Latest Information Update: 16 Oct 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Duramed Pharmaceuticals Inc
  • Class Estradiol congeners; Hormonal replacements; Osteoporosis therapies
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Atrophic vaginitis; Postmenopausal osteoporosis; Vasomotor symptoms

Most Recent Events

  • 20 Oct 2004 Data presented at the 15th Annual Meeting of the North American Menopause Society (NAMS-2004) have been added to the Women's Health therapeutic trials section
  • 06 May 2004 Cenestin® 0.45mg tablets launched for Menopausal syndrome in USA (PO)
  • 11 Feb 2004 Barr Laboratories has received approval for its sNDA for Cenestin® 0.45mg tablet for the treatment of severe vasomotor symptoms of menopause
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top